Liquid-based papanicolaou test (SurePath) interpretations before histologic diagnosis of endometrial hyperplasias and carcinomas: Study of 272 cases classified by the 2001 Bethesda system

Cancer

Volumn 111, Issue 4, 2007, Pages 217-223

  Thrall, Michael ^a   Kjeldahl, Klint ^b   Gulbahce, H Evin ^a   Pambuccian, Stefan E ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL CENTER   (United States)

Author keywords

Abnormal glandular cells; Adenocarcinoma; Benign appearing endometrial cells; Cervicovaginal cytology; Complex hyperplasia

Indexed keywords

ADULT; AGED; ARTICLE; BETHESDA SYSTEM; CANCER CLASSIFICATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENDOMETRIUM CARCINOMA; ENDOMETRIUM CELL; ENDOMETRIUM HYPERPLASIA; FEMALE; HEALTH CARE SYSTEM; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MULTIHOSPITAL SYSTEM; PAPANICOLAOU TEST; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CYTOLOGY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; VAGINAL SMEARS;

EID: 34548136649     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22770     Document Type: Article

References (36)

1. Papanicolaou GN, Traut HF. Diagnosis of Uterine Cancer by the Vaginal Smear. New York, NY: The Commonwealth Fund; 1943.
2. Koss LG, Durfee GR. Cytologic diagnosis of endometrial carcinoma. Result of ten years of experience. Acta Cytol. 1962;6:519-531.
3. Vuopala S. Diagnostic accuracy and clinical applicability of cytological and histological methods for investigating endometrial carcinoma. Acta Obstet Gynecol Scand. 1977;70(suppl):1-72.
4. Koss LG, Schreiber K, Moussouris H, Oberlander SG. Endometrial carcinoma and its precursors: detection and screening. Clin Obstet Gynecol. 1982;25:49-61.
5. Anderson DG, Eaton CJ, Galinkin LJ, Newton CW, Haines JP, Miller NF. The cytologic diagnosis of endometrial adenocarcinoma. Am J Obstet Gynecol. 1976;125:376-383.
6. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002;287:2114-2119.
7. Fadare O, Ghofrani M, Chacho MS, Parkash V. The significance of benign endometrial cells in cervicovaginal smears. Adv Anat Pathol. 2005;12:274-287.
8. Greenspan DL, Cardillo M, Davey DD, Heller DS, Moriarty AT. Endometrial cells in cervical cytology: review of cytological features and clinical assessment. J Low Genit Tract Dis. 2006;10:111-122.
9. Schnatz PF, Guile M, O'Sullivan DM, Sorosky JI. Clinical significance of atypical glandular cells on cervical cytology. Obstet Gynecol. 2006;107:701-708.
10. Mazur MT. Endometrial hyperplasia/adenocarcinoma. a conventional approach. Ann Diagn Pathol. 2005;9:174-181.
11. Newcombe RG. Interval estimation for the difference between independent proportions: comparison of eleven methods. Stat Med. 1998;17:873-890.
12. U.S. Cancer Statistics Working Group. United States Cancer Statistics: 2002 Incidence and Mortality. Atlanta, Ga: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2005.
13. U.S. Census Bureau. Census 2000 Data for the State of Minnesota. Sex by Single Years of Age (PCT12). Washington, DC: Government Printing Office; 2002.
14. Trimble CL, Kauderer J, Zaino R, et al. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study. Cancer. 2006;106:812-819.
15. Hecht JL, Mutter GL. Molecular and pathologic aspects of endometrial carcinogenesis. J Clin Oncol. 2006;24:4783-4791.
16. Zaino RJ. Endometrial hyperplasia: is it time for a quantum leap to a new classification? Int J Gynecol Pathol. 2000;19:314-321.
17. Mutter GL. Histopathology of genetically defined endometrial precancers. Int J Gynecol Pathol. 2000;19:301-309.
18. Eddy GL, Wojtowycz MA, Piraino PS, Mazur MT. Papanicolaou smears by the Bethesda System in endometrial malignancy: utility and prognostic importance. Obstet Gynecol. 1997;90:999-1003.
19. Siebers AG, Verbeek AL, Massuger LF, Grefte JM, Bulten J. Normal appearing endometrial cells in cervical smears of asymptomatic postmenopausal women have predictive value for significant endometrial pathology. Int J Gynecol Cancer. 2006;16:1069-1074.
20. Browne TJ, Genest DR, Cibas ES. The clinical significance of benign-appearing endometrial cells on a Papanicolaou test in women 40 years or older. Am J Clin Pathol. 2005;124:834-837.
21. Clark TJ, ter Riet G, Coomarasamy A, Khan KS. Bias associated with delayed verification in test accuracy studies: accuracy of tests for endometrial hyperplasia may be much higher than we think [review]! BMC Med. 2004;2:18.
22. Bibbo M, Rice AM, Wied GL, Zuspan FP. Comparative specificity and sensitivity of routine cytologic examinations and the Gravlee jet wash technique for diagnosis of endometrial changes. Obstet Gynecol. 1974;43:253-256.
23. Burk JR, Lehman HF, Wolf FS. Inadequacy of Papanicolaou smears in the detection of endometrial cancer. N Engl J Med. 1974;291:191-192.
24. Bibbo M, Reale FR, Reale JC, et al. Assessment of three sampling techniques to detect endometrial cancer and its precursors. A preliminary report. Acta Cytol. 1979;23:353-359.
25. Lozowski MS, Mishriki Y, Solitare GB. Factors determining the degree of endometrial exfoliation and their diagnostic implications in endometrial adenocarcinoma. Acta Cytol. 1986;30:623-527.
26. Schneider ML, Wortmann M, Weigel A. Influence of the histologic and cytologic grade and the clinical and postsurgical stage on the rate of endometrial carcinoma detection by cervical cytology. Acta Cytol. 1986;30:616-622.
27. Kuebler DL, Nikrui N, Bell DA. Cytologic features of endometrial papillary serous carcinoma. Acta Cytol. 1989;33:120-126.
28. Larson DM, Johnson KK, Reyes CN Jr, Broste SK. Prognostic significance of malignant cervical cytology in patients with endometrial cancer. Obstet Gynecol. 1994;84:399-403.
29. Zuna RE, Erroll M. Utility of the cervical cytologic smear in assessing endocervical involvement by endometrial carcinoma. Acta Cytol. 1996;40:878-884.
30. Fukuda K, Mori M, Uchiyama M, et al. Preoperative cervical cytology in endometrial carcinoma and its clinicopathologic relevance. Gynecol Oncol. 1999;72:273-277.
31. Gu M, Shi W, Barakat RR, Thaler HT, Saigo PE. Pap smears in women with endometrial carcinoma. Acta Cytol. 2001;45:555-560.
32. Morimura Y, Nishiyama H, Hashimoto T, et al. Diagnosing endometrial carcinoma with cervical involvement by cervical cytology. Acta Cytol. 2002;46:284-290.
33. DuBeshter B, Deuel C, Gillis S, Glantz C, Angel C, Guzick D. Endometrial cancer: the potential role of cervical cytology in current surgical staging. Obstet Gynecol. 2003;101:445-450.
34. Brown AK, Gillis S, Deuel C, Angel C, Glantz C, Dubeshter B. Abnormal cervical cytology: a risk factor for endometrial cancer recurrence. Int J Gynecol Cancer. 2005;15:517-522.
35. Sherman ME, Dasgupta A, Schiffman M, Nayar R, Solomon D. The Bethesda Interobserver Reproducibility Study (BIRST): a web-based assessment of the Bethesda 2001 System for classifying cervical cytology. Cancer (Cancer Cytopathol). 2007;111:15-25.
36. Kapali M, Agaram NP, Dabbs D, Kanbour A, White S, Austin RM. Routine endometrial sampling of asymptomatic premenopausal women shedding normal endometrial cells in Papanicolaou tests is not cost effective. Cancer (Cancer Cytopathol). 2007;111:26-33.